VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2021 | Surgery for oligometastatic lung cancer

Paul Van Schil, MD, PhD, Antwerp University Hospital, Edegem, Belgium, discusses the role of surgery in patients with oligometastatic lung cancer, highlighting the use of local consolidative treatment for patients with limited metastatic disease and giving a case study as an example. Prof. Van Schil summarizes data on the use of surgery in patients with oligometastatic lung cancer, highlighting the importance of complete nodal dissection to determine prognosis, and data from a randomized Phase II trial investigating local consolidative therapy versus maintenance therapy in patients with limited metastatic lung cancer. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.

Disclosures

Paul Van Schil, MD, PhD, has acted as an external expert for MSD, AstraZeneca and the National Cancer Institute of France; has received institutional fees from the Belgian Association for Cardio-Thoracic Surgery (BACTS) and is a board member of the IASLC.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter